# André-Jacques Auberton-Hervé

> André-Jacques Auberton-Hervé is a seed investor at Soitec backing Medical and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Soitec](https://shizune.co/investors/profile/soitec)
- Location: Grenoble, France
- Total investments: 2
- Last investment: Jan 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/andr%C3%A9-jacques-auberton-herve-22632147

André-Jacques Auberton-Hervé is a seed investor at Soitec in Grenoble focused on Medical and Biotechnology. Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cutâ„¢ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LinKinVax | LinKinVax operates as a clinical-stage biotechnology company. LinKinVax is developing an innovative protein-based vaccine platform that can accelerate availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). | $7.8M | Series A | Jan 09, 2023 |  |
| LinKinVax | LinKinVax operates as a clinical-stage biotechnology company. LinKinVax is developing an innovative protein-based vaccine platform that can accelerate availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). | $5M | Seed | Feb 10, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [IQT](https://shizune.co/investors/profile/in-q-tel) — VC Fund, 1 deal together

## About Soitec

VC Fund · Bernin, France

For more than a decade, Soitec has helped IC manufacturers reap the benefits of silicon-on-insulator (SOI) wafers on an industrial scale, thanks to its unique Smart Cut™ technology, which is key to producing these advanced substrates in volume quantities. Today, the company is the world’s leading supplier of SOI wafers, as well as an innovationleader in this important growth market–serving as a catalyst for collaboration and materials innovation in SOI and other engineered substrates. Soitec leverages its patented Smart Cut technology to manufacture a comprehensive portfolio of SOI and other engineered substrates. With its proven ability to deliver competitive production advantages, as well as the productivity needed to support mass SOI adoption, Smart Cut has enabled Soitec to further strengthen its position as the technological and industrial leader at a time when the market is seeing extremely strong growth.

5 contacts available at Soitec.

| Name | Title | Profile |
| --- | --- | --- |
| André-Jacques Auberton-Hervé | President, CEO and Chairman | https://shizune.co/investors/profile/andr-jacques-auberton-herve |
| Alain Delpy | Business Development Manager Imager, Silicon Photonics, MEMS | https://shizune.co/investors/profile/alain-delpy |
| André-Jacques Auberton-Hervé | President, CEO and Chairman | https://shizune.co/investors/profile/dr-andr-jacques-auberton-herv |
| Carlos Mazure | Chief Technology Officer | https://shizune.co/investors/profile/carlos-mazure |
| Iain Murray | Chief Financial Officer (CFO) | https://shizune.co/investors/profile/iain-murray |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in Europe](https://shizune.co/investors/medical-angel-investors-europe)
- [Medical Investors in France](https://shizune.co/investors/medical-investors-france)
- [Medical Angel Investors in France](https://shizune.co/investors/medical-angel-investors-france)
- [Biotechnology Angel Investors in Europe](https://shizune.co/investors/biotechnology-angel-investors-europe)
- [Biotechnology Angel Investors in France](https://shizune.co/investors/biotechnology-angel-investors-france)
- [Biotech Angel Investors in France](https://shizune.co/investors/biotech-angel-investors-france)

## FAQ

### What does André-Jacques Auberton-Hervé invest in?

André-Jacques Auberton-Hervé invests primarily in Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did André-Jacques Auberton-Hervé last invest?

The most recent investment recorded for André-Jacques Auberton-Hervé closed in Jan 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co